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ABSTRACT 
Laura E Fabricant: The Utility of Obsessive Compulsive Analogue Research: A Comparison of 
OCD Patient, Analogue, and Nonclinical Samples 
(Under the direction of Jonathan Abramowitz) 
 
Many researchers interested in studying obsessive compulsive disorder (OCD) often 
include individuals who do not meet full diagnostic criteria for OCD, but who experience some 
obsessive compulsive (OC) symptoms, as study participants.  While research using these 
analogue samples is common, it is unclear as to how closely they resemble samples of 
individuals with a diagnosis of OCD. The current study thus examined the relationship between 
analogue and clinical samples in order to better understand the generalizability of data from these 
analogue samples. Specifically, this study compared an OC analogue sample to an OCD clinical 
sample, as well as to a healthy control group, on the following domains: OC symptom content, 
the frequency and severity of both obsessions and compulsions, distress and interference related 
to these symptoms, endorsement of obsessional beliefs that contribute to the development and 
maintenance of OC symptoms, and rates of psychiatric comorbidity.  
We found that the analogue group scored below the clinical group, and above the control 
group, on measures of OC symptom severity, frequency, and impairment. Furthermore, the 
analogue group did not differ from the clinical group, but did differ from controls, in terms of 
OC symmetry symptoms, the presence of both obsessions and compulsions across content areas, 
and patterns of comorbidity. Finally, an important area of difference between sub-clinical and 
clinical OCD may be in the relationship between obsessional beliefs and OC symptoms. Taken 
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together these results provide general support for the use and utility of OC analogue samples and 
are largely consistent with dimensional perspectives of OCD.  
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INTRODUCTION 
 
 Obsessive compulsive disorder (OCD) is a complex and disabling condition characterized 
by intrusive, unwanted thoughts or images that lead to increased anxiety (obsessions) and by 
repetitious, intentional rituals that are performed to neutralize the anxiety (compulsions) 
(American Psychiatric Association, 2013). Although OCD only affects approximately 2-3% of 
adults (Karno, Golding, Sorenson, & Burnam, 1988; Kessler et al., 2005), research shows that 
80-90%  of  the  population  experiences  unwanted,  intrusive  “obsession-like”  thoughts  (Rachman  
& de Silva, 1978). While these types of thoughts may differ from clinical obsessions in terms of 
their frequency and intensity, they are similar in content and form to clinical obsessions. That is, 
they can be images, impulses, doubts, and fears that are personally relevant, but unwanted, 
seemingly uncontrollable, and ego-dystonic (e.g. the thought of stabbing a loved one, the image 
of having sex with  one’s  sibling).  Furthermore,  many  individuals  who  do  not  have  OCD  still  
report experiencing at least some distress associated with their unwanted intrusive thoughts, and 
they respond to these thoughts as do people with OCD (Ladouceur et al., 2000).  Given this, and 
the relatively low prevalence of people who meet full diagnostic criteria for OCD, many 
researchers interested in studying this disorder often include individuals who do not meet full 
diagnostic criteria for OCD, but who experience some obsessive compulsive (OC) symptoms, as 
study participants.  This allows for the collection of data from a larger sample more quickly than 
would be possible with using only patients diagnosed with OCD.  
While research using these sub-clinical  or  “analogue”  samples  is  common,  there  is  debate  
in the field regarding how to best define analogue OCD samples, the nature of this sub-clinical 
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phenomenon, and most importantly, the overall utility of this type of research. A recent review 
(Abramowitz et al., 2014) suggested that research using these types of samples is likely to be 
relevant to understanding OCD; however this question has yet to be examined empirically. 
Specifically, no study to date has compared analogue samples to clinical samples across 
clinically relevant domains. Thus, although it is taken for granted, there are no empirical data 
that specifically speak to how closely analogue samples resemble samples of individuals with a 
diagnosis of OCD. It is becoming increasingly necessary to understand the utility of analogue 
OCD research given its growing prevalence in the field. Accordingly, the present study attempts 
to answer questions about the relationship between analogue and clinical samples in order to 
better understand the generalizability of data from these analogue samples.  
Defining OC Analogue Samples 
There is currently no universally agreed upon definition of what constitutes an OC 
analogue sample.  In a literal sense, it refers to individuals who are thought to be comparable in 
some way to those with OCD. Historically, this has included research with animals, such as dogs 
that were conditioned to engage in behaviors similar to those seen in OCD and then subjected to 
extinction procedures reminiscent of modern exposure-based treatments (e.g. Solomon, Kamin, 
& Wynne, 1953). While research using animal analogues of OC symptoms still exists, the utility 
and theoretical basis of some of the more recent animal models of OCD (e.g., dogs that 
“compulsively”  chase  their  tail;;  Dodman,  2006)  has been criticized since only behaviors (as 
opposed to cognitions) are measurable in animals, and it is anthropomorphic to assume that 
animals are performing such behaviors in response to unwanted, intrusive thoughts 
(Abramowitz, Taylor, McKay, & Deacon, 2011).   
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In current human research, analogue OC samples are most often composed of non-
treatment seeking individuals (e.g. undergraduate students) who do not meet full diagnostic 
criteria for OCD, but report experiencing some OC symptoms (e.g., they score highly on 
measures of OC symptoms; Fullana et al., 2007; Taberner, et al., 2009). While drawn from a 
nonclinical population, these individuals display “sub-clinical”  presentations of OCD. For 
example, they might experience obsessions and compulsions, but not significant distress or 
interference relating to these symptoms (de Bruijn, Beun, de Graaf, ten Have, & Denys, 2010). It 
is thought that since these individuals experience some symptoms of OCD, they will be generally 
analogous to clinical samples. Given that the vast majority of studies employing analogue 
samples use individuals with sub-clinical  presentations  of  OCD,  the  terms  “analogue”  and  “sub-
clinical”  will  be  used interchangeably in the current paper.  
Theoretical Basis Underlying the Use of Analogue Samples 
Cognitive behavioral model. The use of analogue samples, in particular the idea that 
sub-clinical OC symptoms are analogous to OCD, has largely emerged from the cognitive 
behavioral (CB) conceptualization of OCD. This well-articulated and empirically supported 
model posits that clinical obsessions develop as a result of misinterpreting normally occurring 
unwanted, intrusive thoughts (Rachman, 1997). In a seminal study, Rachman and de Silva (1978) 
found that the majority of the general population reported experiencing unwanted, intrusive 
thoughts that were often indistinguishable from clinical obsessions in content and form. These 
results have been reproduced in a number of other studies, which indicate that between 80% and 
99% of healthy individuals report having obsession-like intrusive thoughts (e.g. Clark, 1992; 
Clark & de Silva, 1985; Freeston, Ladouceur, Thibodeau & Gagnon, 1991, 1992; Purdon & 
Clark, 1993, 1994; Salkovskis & Harrison, 1984).  
  4 
The CB model argues that these thoughts become obsessions when they are interpreted as 
being overly important, dangerous, or threatening, because this misinterpretation leads to 
anxiety, a preoccupation with the thought, and the urge to resist or control it (Rachman, 1997; 
Salkovskis, 1991). For example, one might believe that having a harmless  thought  such  as,  “I  
could  use  that  knife  to  stab  my  spouse,”  is  actually  indicative  of  deep-seated violent tendencies, 
or that having the thought makes this event more likely to happen. While appraising thoughts in 
this way is a core feature of OCD, a number of studies have found that this process also occurs in 
the general population (e.g. Belloch, Morillo, Lucero, Cabedo & Carrió, 2004; Salkovskis & 
Campbell, 1994). It is thus clear that obsessive thoughts and negative appraisals of these 
thoughts are not unique to a clinical population. 
There is also evidence based on the CB model that compulsions do not occur exclusively 
in clinical samples. In this model, compulsions are defined as maladaptive responses to 
obsessions that are performed to minimize or prevent feared consequences and to reduce distress 
(Salkovskis, 1991). In this way, obsessions and compulsions have a functional relationship. 
While initial conceptualizations of OCD included only overt, behavioral compulsions (e.g. 
checking, washing; Teasdale, 1974), current conceptualizations broadly classify compulsions as 
“safety-seeking  behaviors”  and  include  reassurance  seeking,  avoidance,  neutralizing,  as  well  as  
rituals (Salkovskis, 1991). Though these strategies reduce distress and anxiety in the short-term, 
they  maintain  the  salience  of  the  thoughts  over  time  by  increasing  one’s  preoccupation  with  the  
thoughts and preventing erroneous beliefs about the thoughts from being disproved (Roper & 
Rachman, 1976; Salkovskis, Thorpe, Wahl, Wroe, & Forrester, 2003). A number of studies have 
found that these responses occur in the general population and function in a similar way (Burns 
et al., 1995; Frost, Lahart, Dugas, & Sher, 1988; Frost, Sher, & Geen, 1986).  
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Broadly, the CB model of OCD suggests that obsessions and compulsions can be 
experienced  by  individuals  without  “full-blown”  OCD  and  thus  serves  as  a  foundation  for  
examining OCD symptoms outside of clinical samples. Importantly, this model does not rely on 
a categorical framework for understanding OCD (i.e., present or absent) and instead emphasizes 
the factors that contribute to the development and maintenance of OCD symptoms. According to 
this  model  there  is  a  progression  from  “normal”  thoughts  and  behaviors  to  clinical  obsessions  
and compulsions.  
Dimensional models of psychopathology. The CB model exists within the context of a 
broader dimensional framework for understanding psychopathology. Our current system of 
diagnostic classification, the Diagnostic and Statistical Manual of Mental Disorders (DSM-5; 
American Psychiatric Association, 2013), relies upon a categorical conceptualization of 
psychopathology. According to this approach either a disorder is present, or it is not. Researchers 
have recognized the limitations of this approach since the advent of the current classification 
system, expressing concern that psychopathology and impairment extend beyond diagnostic 
thresholds, and emphasizing observable evidence of a continuum (Apter et al., 1996; Carson, 
1991; Frances at al., 1991; Millon, 1991; Stein, Walker & Forde, 1994). However, the concern 
that categorical conceptualizations of psychopathology may not correspond with how these 
phenomena occur in nature seems to be increasing (Kessler et al., 2003; Krueger & Piasecki, 
2002; Maser & Patterson, 2002; Regier, 2007), as is the evidence for a more dimensional 
approach (Holland & Kuppens, 2012). When viewed in the context of this evidence, categorical 
views of psychopathology seem to simply establish a point on the continuum at which 
psychopathology will be considered pathological rather than reflect the true nature of 
psychopathology.  
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Some of the most compelling evidence supporting a dimensional model of 
psychopathology has come from taxometric research. Meehl and colleagues (Meehl, 1995; 
Waller & Meehl, 1998) developed taxometric procedures to examine the latent structure of 
psychological phenomena and thus determine the nature of this structure (i.e. categorical or 
dimensional). Results from these statistically sophisticated studies broadly suggest that most 
groups of mental disorders, including anxiety disorders, are dimensional (see Haslam, 2003; 
Haslam, Holland & Kuppens, 2012 for reviews). Two studies to date have specifically focused 
on examining the latent structure of OCD. One of these studies examined three OC symptom 
domains and found strong support for the dimensional models of contamination and checking 
symptoms,  but  mixed  support  for  a  dimensional  model  of  “obsessionality”  (Haslam  et  al.,  2005).  
The second study found evidence that strongly and consistently supported a dimensional latent 
structure for all OCD symptoms as measured by the OCI-R (Olatunji, Williams, Haslam, 
Abramowitz, & Tolin, 2008). These studies thus provide empirical support for a dimensional 
model of OCD.  
When these findings are considered in concert with the larger movement in the field 
toward a more dimensional view of psychopathology as well as with the CB model of OCD, it 
appears that OCD it best conceptualized as occurring on a continuum, rather than in discrete 
categories. Since conclusions drawn from research with analogue samples are thought to have 
more merit if psychopathology truly exists on a continuum, these findings thus provide support 
for this type of research. In other words, both the CB model of OCD and a broader dimensional 
view of psychopathology suggest that sub-clinical presentations of psychopathology are 
quantitatively, but not qualitatively, different from clinical presentations, and thus may serve as 
true analogues to clinical samples.  
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Measuring OC Analogue Symptoms 
The majority of research employing analogue samples uses validated self-report measures 
or diagnostic interviews to identify individuals exhibiting elevated scores on these measures. 
Despite similar methods in identifying analogue cases, there is a lack of consistency in 
measuring analogue OCD, as both different measures and different cut-off points are used. The 
most commonly employed self-report measures include the Maudsley Obsessional Compulsive 
Inventory (MOCI; Hodgson & Rachman, 1977), the Padua Inventory (PI; Burns, Keortge, 
Formea, & Sternberger, 1996), and the Obsessive-Compulsive Inventory- Revised (OCI-R; Foa 
et al., 2002). Each of these scales measures slightly different aspects of OC symptoms: the 
MOCI is more behaviorally focused, the PI targets distress associated with specific experiences, 
and the OCI-R is more comprehensive. It is thus likely that studies using these measures to 
identify OC analogue samples are capturing slightly different definitions of this phenomenon.  
In addition to measuring different aspects of OC symptomatology, these measures are 
used differently throughout the field. That is, previous studies using either the MOCI or the PI to 
identify analogue samples have used a large variety of cut-off points on these measures (ranging 
from including the individuals with the highest 2-25% of scores on these measures; Frost et al., 
1994; Gibbs, 1996; Sternberger & Burns, 1990). Additionally, while some of these studies have 
used total scores (e.g. Frost et al., 1994), other studies have used scores from various subscales 
(e.g. Olatunji, Connolly, Lohr, & Elwood, 2008). The OCI-R is generally used more consistently 
than the MOCI and PI, as Foa and colleagues (2002) published optimal cut-off scores based on 
the sensitivity and specificity of the measure. Thus, researchers using analogue samples often use 
the cut-off score that best discriminates between non-anxious controls and patients with OCD.  
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There is slightly more consistency in the use of diagnostic interviews to identify analogue 
OCD subjects, with many studies administering the OCD module of a structured diagnostic 
interview [e.g. Composite International Diagnostic Interview (CIDI; Kessler & Ustun, 2004)]. 
Individuals who report experiencing obsessions and/or compulsions on interview, but who do not 
meet all diagnostic criteria are then identified as having sub-clinical or analogue OCD (e.g. 
Adam et al., 2012). However, this varies as well; some studies define analogue samples as the 
presence of any OC symptom, while others require more than one symptom, or some degree of 
distress or interference.  
Interestingly,  the  “gold-standard”  measure  of  OCD  symptoms,  the  Yale  Brown  Obsessive 
Compulsive Scale (Y-BOCS; Goodman, Price, Rasmussen, & Mazure, 1989a, 1989b), is rarely 
used to select analogue samples. This interview includes a 10-item severity scale that is 
frequently used to identify clinical samples, as well as measure symptom change over time. 
Individuals who score below the established clinical cut-off on this scale, but who endorse some 
degree of symptom severity would thus qualify as sub-clinical or analogue cases (Tolin, 
Abramowitz, & Diefenbach, 2005). While using this measure to identify sub-clinical OCD 
would be highly appropriate, it is much more thorough than the OCD modules of most structured 
diagnostic interviews, and thus requires more time to administer. This may explain its limited use 
in this context.  
 Considering the above concerns with measuring analogue OCD, the present study 
administered the most consistently used self-report measure of OC symptoms--the OCI-R-- to 
identify participants as OC analogues. We also employed the gold-standard interview measure 
(the Y-BOCS) to assess symptom severity.  
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The Use of Analogue Samples 
There is a long history of using analogue samples in research on anxiety disorders and 
related phenomena. Even prior to the development and testing of the CB model, researchers 
identified sub-clinical individuals as potentially analogous participants in a range of studies. The 
first documented use of an analogue sample in anxiety research was a study on systematic 
desensitization that used  “snake-fearful”  college  students  to  study  fear  reduction  (Lang  &  
Lazovik, 1963). This landmark study became a template for future research using analogue 
samples and many such studies followed. It is possible that the increasing interest in studying 
behavioral theories and techniques lent itself to the use of these analogue samples, but the ease of 
recruitment undoubtedly played a role. Since this time, studies using analogue samples have 
become quite common and are used within the context of a variety of different methodologies 
(e.g. correlational, experimental).  
 A number of these studies have examined associated features or psychological 
mechanisms that are thought to broadly relate to OCD (e.g. anxiety sensitivity); however, the 
constructs of interest in these studies vary widely. In fact, OCD analogue samples are used in 
precisely the same way OCD samples are: to study any and all variables associated with the 
development, maintenance and even treatment of this disorder. These types of samples have been 
used to study everything from disgust sensitivity (Deacon & Olatunji, 2007) to prospective 
memory (Cuttler & Taylor, 2012) to treatment response (Cougle, Wolitzky-Taylor, Lee, & 
Telch, 2007) in OCD. Much of this research also focuses on isolating specific aspects of OCD 
(e.g. contamination concerns). Given the breadth of research that employs analogue samples, it is 
clear that this type of research has important implications for our understanding of OCD and 
related constructs.   
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Benefits of analogue samples. Perhaps the most apparent benefit of using analogue 
samples relates to participant recruitment and enrollment. Since OCD occurs in a relatively small 
percentage of the general population, it can be time intensive and costly to recruit clinical 
samples of an adequate size. This is exacerbated by the fact that much of the research being 
conducted on OCD occurs in academic, rather than clinical, settings; thus placing the target 
population further out of reach. However, since many OC symptoms commonly occur in the 
general population, and sub-clinical OCD occurs more commonly than OCD (Adam at al., 2012; 
de Brujin at al., 2010; Fineberg et al., 2013), using participants with some degree of OC 
symptomatology allows researchers to cast a larger recruitment net. In other words, using 
analogue samples allows researchers to recruit larger samples more easily. This is an important 
point as the feasibility of any study is necessary to consider. It is likely that using analogue 
samples thus allows for more research to be conducted and may make some projects feasible that 
would otherwise be impractical. The ability to recruit larger samples more quickly may be 
especially relevant when considering research on specific symptom patterns (e.g. contamination 
obsessions). Due to the heterogeneity of OCD, only a sub-set of individuals with OCD 
experience any given symptom dimension. It can thus be very difficult to study these domains in 
clinical samples. Analogue samples provide an opportunity to examine more homogenous 
symptomatology, which also facilitates more basic research.  
 Additionally, using analogue samples rather than clinical samples may allow researchers 
to avoid some concerns relevant to research using clinical populations. First, since individuals 
with sub-clinical OCD are much less likely to seek treatment (Adam et al., 2012), using these 
samples reduces possible treatment confounds. This issue is, of course, most relevant in studies 
with multiple time points (e.g. prospective studies). Second, in studying clinical samples there 
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are often concerns regarding selection bias. That is, while it is common to recruit from treatment 
facilities, the population then being studied is not truly individuals with OCD, but individuals 
seeking treatment for OCD. There are likely to be differences between these populations. Since 
sub-clinical samples are generally screened samples recruited from the general population, this 
avoids this particular selection bias. Finally, in conducting studies of treatment components or 
mechanisms with clinical populations, there is an ethical concern in assigning a treatment-
seeking patient with OCD to a control group that does not include active treatment. This concern 
is partially alleviated in studying non-treatment-seeking samples.  
Limitations of analogue samples. Of course, the primary limitation in using analogue 
OCD samples is that these are not truly OCD samples, thus raising concerns about both internal 
and external validity. Researchers cannot be certain that (a) analogue samples are truly similar to 
OCD samples and (b) results obtained in studying analogue OCD will generalize to clinical 
OCD. The tentativeness that currently exists regarding this issue limits the utility of these 
studies. That is, results from analogue studies are frequently treated with caution and a 
disclaimer is commonly highlighted: these findings must be replicated in clinical samples before 
we can understand how our results relate to individuals with OCD. While replication is an 
important aspect of the scientific method, requiring this to occur before the results can even be 
interpreted with regard to OCD may negate the utility of analogue research. Despite the 
inconvenience of this approach, this caution seems appropriate given our current limited 
understanding of sub-clinical OCD. It is also possible to consider that analogue studies may have 
value even if they cannot stand on their own. That is, they may serve to identify constructs of 
interest in OCD research and thus facilitate the optimal use of clinical samples. The present study 
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thus sought to expand our current understanding of the comparability of OCD analogue samples 
by comparing this type of sample to a clinical sample on a number of domains.  
The Relationship Between Analogue and Clinical OCD  
  While there is a growing body of research examining OC symptoms and related domains 
in analogue samples, and a long history of research examining these constructs in individuals 
diagnosed with OCD, there is little research directly comparing these samples. Furthermore, 
much of the research that does compare clinical groups to non-clinical groups does this using 
unscreened samples, rather than true analogue samples. Thus, there remain a number of 
unanswered questions regarding how analogue and clinical samples compare to each other. The 
following sections compare the findings from nonclinical and clinical samples across a number 
of domains in an effort to understand the specific questions that remain unanswered.  
OCD symptoms. The presence of obsessions and compulsions. Previous research has 
examined the distinction between non-clinical and clinical obsessions and compulsions; 
however, very little of this research has focused on the differences between the obsessions and 
compulsions seen in sub-clinical and clinical OCD. Early research in this area compared the 
symptom profiles of non-clinical individuals with clinical individuals and found that while the 
vast majority of those with clinical OCD experienced both obsessions and compulsions 
(Rasmussen & Tsuang, 1986), this was not the case in non-clinical samples (Karno, et al., 1988; 
Weissman et al., 1994). Instead, these studies found that the majority of individuals in non-
clinical populations who reported OCD symptoms experienced only obsessions or compulsions. 
They also found that individuals in non-clinical populations tended to experience these 
symptoms less frequently than those with OCD. These findings suggest that frequency as well as 
the experience of both obsessions and compulsions may be ways in which clinical OCD differs 
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from sub-clinical symptoms. This may represent a noteworthy difference between clinical and 
analogue samples, as experiencing compulsions without obsessions contradicts the functional 
model of OCD (Salkovskis, 1991). However, these results should be interpreted with caution, as 
there are a number of possible explanations for these findings, and research directly comparing 
analogue samples to clinical samples is needed.  
One explanation for the above findings is that a functional relationship does not exist 
between obsessions and compulsions in non-clinical samples (Gibbs, 1996). Relatedly, it may be 
that  individuals  with  “pure  obsessions”  are  more  likely  to  exhibit  sub-clinical OCD symptoms, 
rather than meet full diagnostic criteria for OCD. That is, if an individual experiences less 
distress and anxiety associated with their obsessional thoughts, they may be less likely to attempt 
to reduce that distress and anxiety by engaging in compulsions. However, it is also possible that 
a different definition of compulsions may account for these findings. While current 
conceptualizations of compulsions include subtle, internal behaviors such as mental reviewing, 
reassurance-seeking, and avoidance (Salkovskis, 1991), it was previously common to only 
classify overt, external behaviors (e.g. washing) as compulsions (Teasdale, 1974). It may be that 
these early studies did not take these subtle safety-seeking behaviors into account, and thus 
classified individuals with subtle safety-seeking behaviors  as  having  “pure  obsessions”.  It  is  also  
possible  that  individuals  could  have  been  identified  as  having  “compulsions  only”  due  to  a  
different definition of compulsions (i.e. any repetitive behavior) or the presence of subtle 
obsessions. In these non-clinical samples it is likely that there is less distress associated with the 
experience of obsessions, and thus they may be more difficult to assess. 
An additional concern with the above findings is that these two studies both used the 
OCD module of the Diagnostic Interview Schedule to assess the presence of obsessions and 
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compulsions. This measure does not acquire detailed information about obsessions and 
compulsions and instead relies on simple yes/no questions that may be easy to misinterpret, 
especially in samples from the general population. Given these concerns, it is not currently clear 
as to whether sub-clinical presentations of OCD differ from clinical presentations in terms of the 
presence of both obsessions and compulsions. In order to understand whether this is an important 
area of difference between analogue and clinical samples, it is necessary to thoroughly examine 
the presence of obsessions and compulsions in analogue samples and compare this to patterns 
observed in clinical samples.  Accordingly, this is one of the aims of the present study.  
Content of obsessions and compulsions. The content of obsessions and compulsions is 
heterogeneous in nature, varying substantially across individuals. Structural analyses indicate 
that particular obsessions and compulsions tend to co-occur, creating dimensions or sub-types of 
OCD (Mataix-Cols, Rosario-Campos, & Leckman, 2005; McKay et al., 2004). The most 
consistently replicated of these OC symptom dimensions include: contamination, responsibility 
for harm and mistakes, symmetry/ordering, and unacceptable thoughts (Abramowitz et al., 
2010).  While these dimensions appear to be fairly distinct, it is common for individuals with 
OCD to report the presence of obsessions and compulsions across multiple symptom dimensions 
(McKay et al., 2004). Given the heterogeneity of OC symptom presentation, it is possible that 
clinical and analogue samples differ with regard to the types of symptoms commonly reported in 
each sample. However, previous research has found little difference between the content of the 
obsessions and compulsions experienced by individuals with and without OCD. It is important to 
note that again much of this research has been conducted using non-clinical rather than sub-
clinical samples.  
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Obsessions. Overall, the content of obsessions appears to be similar in clinical and non-
clinical samples.  That is, both clinical and non-clinical individuals commonly report obsessions 
relating to contamination, fears of harming oneself or others, sex, and aggression/violence 
(Belloch et al., 2004; Garcia-Soriano  et  al.,  2011;;  Julien,  O‘Connor,  &  Aardema,  2009;;  Khanna, 
Kaliaperumal & Channabasavanna, 1990; Parkinson & Rachman, 1980; Purdon & Clark, 1993; 
Rasmussen & Eisen, 1989). Moreover, Rachman and deSilva (1978) found that trained clinicians 
could not distinguish between obsessions reported by clinical and non-clinical individuals based 
on content.  
However, one study to date did find content differences between nonclinical and clinical 
obsessions (Rassin, Cougle & Muris, 2007). This study classified obsessions as either clinical or 
nonclinical and found that students were more likely to endorse a lifetime history of the 
obsessions considered  to  be  “nonclinical”. However, without an OCD control group, the 
implications of these findings are unclear. Julien,  O’Connor,  and  Aardema  (2009) subsequently 
administered a similar questionnaire to both students and individuals with OCD and found that 
these groups did not differ in the prevalence of nonclinical obsessions relative to clinical 
obsessions. This more methodologically rigorous study thus provides additional evidence for the 
view that clinical and nonclinical obsessions are similar in content. The current study sought to 
provide additional support for this by comparing clinical and analogue groups on measures of 
symptom content.  
Compulsions. Previous research has found that many of the compulsions often seen in 
OCD (e.g. checking, counting, repeating) are also common in non-clinical populations (Flament 
et al., 1989; Henderson and Pollard, 1988). Similarly, the covert neutralizing strategies described 
previously appear frequently in both types of samples (e.g., Ladouceur et al., 2000). However, 
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while washing and cleaning compulsions are very common in clinical populations (Khanna et al., 
1990), there is evidence that they might be less common in non-clinical populations (Degonda 
Wyss & Angst, 1993; Valleni-Basile et al., 1994). Gibbs (1996) suggested that this difference 
might exist because individuals with washing compulsions may seek treatment more often, and 
thus be represented more heavily in clinical samples.  She argued that since washing and 
cleaning may be more time-consuming  and  are  considered  to  be  “classic”  symptoms  of  OCD,  
they may facilitate the detection of OCD and treatment-seeking (Gibbs, 1996). Another 
possibility is that it is more challenging to recognize sub-clinical washing and cleaning 
compulsions. Since these are behaviors that most people engage in throughout each day, and 
would generally not be considered compulsions, it may be difficult to assess when these 
behaviors are being performed in response to obsessional thoughts. It is possible, however, that 
differences in the prevalence of washing and cleaning compulsions is a key difference between 
clinical and sub-clinical OCD samples. If this is the case, sub-clinical samples may not be 
appropriate analogues for research focusing on washing and cleaning compulsions.  
Based on this body of research, it appears that OC symptoms are generally similar in 
content and form in clinical and non-clinical populations. There may be differences between 
these groups with regard to the frequency of these symptoms, the presence of both obsessions 
and compulsions, and the presence of washing compulsions. However, this research is not 
conclusive and these constructs have not been examined in sub-clinical, or analogue, samples. 
One of the aims of the current study is thus to clarify the ways in which analogue samples may 
report more or less similar patterns of OC symptoms relative to clinical OCD samples.  
Obsessive Beliefs and OC Symptoms. As discussed above, the CB model of OCD suggests 
that particular types of dysfunctional beliefs are related to the development and maintenance of 
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OCD  symptoms.  Specifically,  researchers  have  identified  six  domains  of  “obsessional  beliefs”  
thought to contribute to OC symptoms (Obsessive Compulsive Cognitions Working Group 
[OCCWG], 1997): 
 Overestimation of threat. Individuals with OCD tend to exaggerate the likelihood and 
severity of harm that is featured in their obsessional thoughts (e.g. “It  is  very  easy  to  contract 
HIV from a toilet seat”; Frost & Steketee, 2002).  
 Inflated sense of responsibility. The belief that one is able to and obligated to prevent 
subjectively important negative events from occurring (e.g.  “Not  preventing harm is as bad 
as causing it”; Frost & Steketee, 2002).  
 Over-importance of thoughts. The belief that merely the occurrence of thoughts implies 
that these thoughts are meaningful and/or dangerous (e.g. “Having  a  thought about having 
sex with my brother means that I want to do it”; Frost & Steketee, 2002).  
 Need to control thoughts. The belief that it is possible and desirable to control thoughts, and 
that exerting this control is very important (e.g. “Having  intrusive  thoughts  means  that  I’m  
out  of  control”; Frost & Steketee, 2002).  
 Perfectionism. The belief that imperfection and mistakes cannot be tolerated (e.g. “Things  
are  not  right  if  they  are  not  perfect”; Frost & Steketee, 2002).  
 Intolerance of uncertainty. The belief that it is necessary to be certain and that ambiguity is 
intolerable and has negative consequences (e.g.  “If  I’m  not  sure  of  something,  I’ll  make  a  
mistake”, Frost & Steketee, 2002).  
Subsequent structural analyses of these six domains revealed that they form three factors: 
overestimates of threat and responsibility, the importance and need to control thoughts, and 
perfectionism and need for certainty (OCCWG, 2003, 2005). While no studies to date have 
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compared the presence of these beliefs in sub-clinical and clinical OCD, there is a large body of 
work examining the relationship between these beliefs and OCD symptoms in both clinical and 
nonclinical samples. In fact, both correlational and experimental studies demonstrate that 
obsessive beliefs are associated with global OC symptom severity in clinical and nonclinical 
samples (Abramowitz et al., 2006; Abramowitz & Deacon, 2006; Lopatka & Rachman, 1995; 
OCCWG, 2003, 2005; Steketee, Frost, & Cohen, 1998; Tolin, Woods, & Abramowitz, 2003).  
Given the heterogeneous nature of OCD, there is also evidence supporting the 
relationship between specific OC symptom dimensions and specific obsessive beliefs. A number 
of studies have addressed this issue by measuring both OC symptoms and obsessional beliefs in 
large groups of OCD patients or nonclinical samples, and then using correlation, regression, 
and/or structural equation modeling techniques to examine relationships between symptoms and 
cognitions.  Results from this body of research suggest a number of trends. First, contamination 
and washing symptoms are often predicted by overestimates of responsibility and/or 
overestimates of threat in both clinical (OCCWG, 2005; Tolin et al., 2008; Wheaton et al., 2010) 
and nonclinical (Mendlowicz et al., 2008; Taylor et al., 2010; Tolin et al., 2003) samples. 
Ordering and arranging symptoms are consistently predicted by perfectionism and/or the need 
for certainty in both clinical (Julien et al., 2006; OCCWG, 2005; Tolin et al., 2008; Wheaton et 
al., 2010) and nonclinical (Abramowitz et al., 2009; Myers et al., 2008; Taylor et al., 2010; Tolin 
et al., 2003) samples. Unacceptable obsessional thoughts have been routinely predicted by 
beliefs about the importance of and need to control thoughts in both clinical (Abramowitz & 
Deacon, 2006; Julien et al., 2006; Tolin et al., 2008; Wheaton et al., 2010) and nonclinical 
(Abramowitz et al., 2009; Myers et al., 2008; Taylor et al., 2010; Tolin et al., 2003) samples.  
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There are some inconsistencies across studies regarding checking symptoms in both 
clinical and nonclinical samples, with some studies implicating perfectionism and the need for 
certainty (Julien et al., 2006; OCCWG, 2005) and others implicating overestimates of 
responsibility and threat (Abramowitz et al., 2009; Wheaton et al., 2010) as being the strongest 
predictor of checking symptoms. It is thus not clear whether perfectionism and the need for 
certainty or overestimates of responsibility and threat represent the best predictor of checking 
symptoms, or if both of these types of beliefs function together in this domain. However, given 
the similar patterns observed in both clinical and nonclinical samples, this is not likely to be an 
area of difference between clinical and nonclinical samples.  
When viewed in concert, previous research indicates that there is a similar relationship 
between obsessional beliefs and OC symptoms in clinical and nonclinical samples. Nevertheless, 
since no study to date has compared the presence and severity of these beliefs in sub-clinical and 
clinical samples, it is not clear how these beliefs may function in analogue samples. The present 
study aims to shed light on this issue by examining multiple domains of obsessional beliefs in 
both an analogue and a clinical sample.  
Distress and impairment. While the distress associated with OC symptoms and 
impairment from these symptoms are separate constructs, they often studied together and play a 
similar role in the current definition of OCD (American Psychiatric Association, 2013). In 
understanding how analogue OCD relates to clinical OCD, this area is perhaps most heralded as 
the distinguishing marker between the two. In fact, it is often used to differentiate between 
clinical and sub-clinical cases. This seems appropriate, given that in order to meet full diagnostic 
criteria for OCD one must experience OC symptoms as well as distress or interference as a result 
of these symptoms (American Psychiatric Association, 2013). We would thus expect analogue 
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samples to report less distress and impairment associated with their OC symptoms than clinical 
samples.    
 While some of the existing research supports this claim, results are fairly mixed. In a 
general community sample, results indicated that 31-42% of people with no mental disorders 
reported having been bothered by obsessions for periods over 2 weeks; 25% reported 
experiencing obsessions for more than 1 hour per day, and 15% reported feeling emotionally 
upset by them (Fullana et al, 2009). Additionally, 33-45% reported performing compulsions for 
periods of more than 2 weeks and 11-12% reported being upset by them (Fullana et al, 2009). 
These results provide clear evidence that individuals in the general population with no 
psychiatric diagnoses experience distress associated with OC symptoms, especially obsessions.  
In studies that have compared sub-clinical and clinical OCD, some have found that 
individuals with sub-clinical OCD experience more distress related to their symptoms than 
healthy controls, but less distress than those with OCD (Grabe et al., 2000), while other studies 
have found no significant differences between clinical and sub-clinical groups in terms of 
distress (de Bruijn et al., 2010; Apter et al., 1996). There is a similar pattern of results in studies 
that have examined impairment related to OCD; some studies have found that those with sub-
clinical OCD experience more impairment than controls, but less than those with OCD (Adam at 
al., 2012; Grabe et al., 2000), while others have found that the sub-clinical group looks very 
much like the OCD group on measures of disability (de Bruijn et al., 2010).  
Taken together, these findings suggest that sub-clinical OCD exists below OCD (and 
above controls) on a continuum of distress and impairment and may be closer to OCD than 
previous research indicated. However, it is too early to state this with certainty, especially given 
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the different measures that have been used to assess distress and interference. The present study 
will seek to replicate these findings with a widely used measure of symptom impairment.  
Psychiatric comorbidity. Given the well-established rates of comorbid Axis I 
psychopathology in OCD, it is important to compare sub-clinical and clinical OCD on this 
domain in order to understand how these samples may be comparable. Rates of comorbid 
psychiatric disorders in clinical OCD populations are consistently high, particularly for mood 
and anxiety disorders.  Estimates for the comorbidity of mood disorders ranges from 30-70% and 
from 40-86% for anxiety disorders (Tukel, Polat, Ozdemir, et al., 2002; Karno et al., 1988). 
Research on patterns of comorbidity in sub-clinical OC samples generally suggests that these 
rates are lower than in clinical samples, but higher than for controls.  
Early research relevant to this topic examined levels of depression and anxiety in non-
clinical samples. Studies that have examined the relationship between OCD symptom severity 
and levels of anxiety and depression have found that OC symptoms are positively associated 
with both depression and other anxiety symptoms (Freeston et al., 1992; Freeston, Ladoucer, 
Rheaume, Letarte, Thibodeau  & Gagnon, 1994; Purdon & Clark, 1993; Tallis & DeSilva, 1992). 
Studies that compared non-clinical individuals who reported some level of OC symptomology 
with those who did not have OC symptoms consistently found that the analogue samples had 
higher levels of depression and anxiety than controls (Burns et al., 1995; Frost et al., 1986; 
Goodwin  &  Sher,  1992;;  Maki,  O’Neill,  &  O’Neill,  1994;;  Sher, Frost, Kushner, Crews, & 
Alexander, 1989; Sher, Martin, Raskin, & Perrigo, 1991).  These results are remarkably similar 
regardless of the specific construct of interest (e.g. worry, state anxiety, etc.), measures used, and 
screening methods.  
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More recent research has compared rates and patterns of co-morbidity between sub-
clinical OCD and clinical OCD and has generally found that sub-clinical, or analogue, groups 
endorse lower rates of psychiatric comorbidity than clinical groups, but higher rates than controls 
(Adam et al., 2012; de Bruijn et al., 2010; Grabe et al., 2001). Sub-clinical groups may differ 
from OCD groups on rates of comorbid mood disorders and anxiety disorders more so than on 
rates of eating disorders, substance related disorders, or schizophrenia (de Brujin et al., 2010). 
The present study sought to replicate these findings and explore any differences between groups 
across psychopathological domains.  
The Current Study: Design and Hypotheses 
  While there is a well-articulated theoretical basis, as well as some empirical evidence, 
supporting the use of analogue samples in research on OCD, it is not yet clear as to how these 
samples compare to clinical samples on a number of important domains. It is thus difficult to 
speak to the generalizability of results that emerge from research using analogue samples. More 
specifically, it is currently not clear how analogue samples compare to clinical samples in terms 
of: OC symptom content, the frequency and severity of both obsessions and compulsions, 
distress and impairment related to these symptoms, endorsement of obsessional beliefs that 
contribute to the development and maintenance of OC symptoms, and rates of psychiatric 
comorbidity. Accordingly, the current study compared an OC analogue sample to an OCD 
clinical sample, as well as to a healthy (non-symptomatic) control group, on the above domains. 
This study represents the first empirical investigation directly evaluating the comparability of an 
OC analogue sample to an OCD sample in this way. In comparing these groups, we evaluated 
not only whether using analogue samples is useful in furthering OCD research, but when and 
how these samples might be more or less comparable to OCD samples. With the growing 
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popularity of OC analogue research, it is becoming increasingly necessary to understand how 
comparable these samples are to clinical samples, and in what ways. 
Given the aforementioned problems in measuring OC symptoms in analogue samples, 
this study used the gold standard measure of OCD (Y-BOCS) to thoroughly assess these 
symptoms across groups. Additionally, this study sought to maximize ecological validity by 
defining the analogue and clinical groups based on the standards commonly used in the field; the 
analogue group was composed of undergraduate students who scored highly on a measure of OC 
symptoms and the clinical group was composed of treatment-seeking individuals diagnosed with 
OCD. 
The current study investigated the following hypotheses: 
Hypothesis 1: OC symptoms. A) The analogue group would score below the clinical 
group, but above the control group on measures of OCD symptom severity and frequency (both 
obsessions and compulsions). While previous research suggests that individuals in non-clinical 
populations may experience either obsessions or compulsions (Karno, et al., 1988; Weissman et 
al., 1994), there are many possible explanations for these findings. Based on the functional 
model of OCD (Salkovskis, 1991), which includes more modern definitions of obsessions and 
compulsions, we expected that, similar to the clinical group, the analogue sample would endorse 
both obsessions and compulsions.  
B) The analogue group would report less severe OC symptoms than the clinical group, 
but more severe symptoms than the control group, within each of the following OC symptom 
content domains: contamination, unacceptable thoughts, responsibility for harm, and 
symmetry/ordering, based on dimensional conceptualizations of OC symptoms.  
  24 
C) There would be no differences between the types of obsessions and compulsions 
endorsed by the three groups based on previous research that has found that a wide range of 
obsessions and compulsions occur outside of clinical samples (Belloch et al., 2004; Henderson & 
Pollard, 1988) and are largely indistinguishable from clinical obsessions and compulsions 
(Julien,  O’Connor,  & Aardema, 2009).  
Hypothesis 2: Obsessional beliefs. A) The analogue group would score below the 
clinical group, but above the control group on measures of OC beliefs related to the development 
and maintenance of OCD. While no previous research has compared these groups on this 
domain, there is evidence that obsessional beliefs occur outside of clinical samples and are 
directly related to symptom severity (Frost & Steketee, 2002).   
B) Additionally, we hypothesized that specific OC symptoms would be related to specific 
obsessional beliefs, and that these patterns would be similar across all three groups based on 
previous research suggesting that similar relationships exist between symptoms and beliefs in 
both clinical and nonclinical samples. Specifically, we hypothesized the following symptom-
cognition associations: contamination and washing symptoms would be related to overestimates 
of responsibility and/or overestimates of threat; unacceptable obsessional thoughts would be 
related to beliefs about the importance of and need to control thoughts; ordering and arranging 
symptoms would be related to beliefs about perfectionism and the need for certainty; 
responsibility for harm and checking symptoms would be related to beliefs about perfectionism 
and the need for certainty and to beliefs about overestimates of responsibility and threat.   
Hypothesis 3: Symptom impairment. The analogue group would score below the 
clinical group, but above the control group on measures of impairment related to OC symptoms 
based on previous research that has found this pattern (Adam at al., 2012; Grabe et al., 2000).   
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Hypothesis 4: Psychiatric comorbidity. The analogue group would score below the 
clinical group, but above the control group on measures of psychiatric comorbidity based on 
previous research that suggests a similar pattern (Adam et al., 2012; de Bruijn et al., 2010).
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METHODS 
Participants  
 Overall sample. The overall sample consisted of 30 males (28.3%) and 76 females 
(71.7%) and was 74.5% Caucasian, 9.4% African-American,  5.7%  Hispanic,  5.7%  “other”, and 
4.7% Asian-American. The mean age of our sample was 24 years and 6 months and ranged from 
age 18-66. One participant discontinued participation during the interview portion of the study 
after reporting current suicidal ideation.  
 OCD group. The OCD group was composed of 35 treatment-seeking adults who met 
diagnostic criteria for OCD, as determined by a trained interviewer using a clinical interview and 
confirmed via validated self-report measures. Participants in this group participated in one of two 
treatment outcome studies addressing OCD conducted at the UNC Psychology Department 
Community Clinic. One treatment study examined the efficacy of a couples-based intervention 
for OCD, the other study compared an acceptance based treatment to traditional exposure and 
response prevention for OCD.  Participants were not excluded if they reported symptoms of 
comorbid conditions. Participants were included in the present study whether or not they chose 
to fully participate in the treatment studies (e.g. if they dropped out during treatment).    
 Analogue group. The analogue group was composed of 25 non treatment-seeking 
individuals who reported the presence of some OC symptoms and scored above the clinical cut-
off score of 18 on the OCI-R (M = 26.20, SD = 6.88). Participants in this group were recruited 
from undergraduate psychology classes (see Procedure section).
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Control group. The control group included 46 non treatment-seeking individuals who 
scored below the clinical cut-off of 18 on the OCI-R (M = 8.35, SD = 4.56). Participants in this 
group were recruited from undergraduate psychology classes (see Procedure section).  
Interviewer-Based Measures 
Mini International Neuropsychiatric Interview (MINI; Sheehan et al., 1998). The 
MINI is a brief, structured diagnostic interview that assesses a selection of the most frequent 
psychiatric diagnoses according to DSM-IV-TR diagnostic criteria.  The MINI has shown high 
inter-rater reliability, and test-retest reliability (Sheehan et al., 1998). In the present study the 
MINI was used to assess diagnostic comorbidity. 
Yale-Brown Obsessive Compulsive Scale (YBOCS; Goodman et al., 1989a, 1989b). 
The YBOCS is a widely used interview measure of global OCD symptom severity that assesses 
obsessions and compulsions, independent of symptom theme, on the following five parameters: 
(a) time spent, (b) interference, (c) distress, (d) resistance, and (e) control. Based on these 
symptoms, the Y-BOCS includes two subscales: Obsessions and Compulsions. The instrument 
also includes a symptom checklist that measures the presence of specific types of obsessions and 
compulsions. The Y-BOCS has demonstrated good reliability and validity (Deacon and 
Abramowitz, 2005; Woody, Steketee & Chambless, 1995). The Y-BOCS displayed excellent 
internal consistency in  the  current  sample  for  both  the  obsessions  subscale  (α  =  .90),  and  the  
compulsions subscale (α  =.92).  In the present study the YBOCS was used to assess OC symptom 
severity as well as OC symptom content.  
Self-Report Measures 
Beck Anxiety Inventory (BAI; Beck & Steer, 1993). The BAI is a 21-item self-report 
measure that assesses the  severity  of  an  individual’s  anxiety  during  the  past  month.  This  measure  
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asks participants to rate how much they are bothered by common symptoms of anxiety (e.g. 
dizziness, nervousness) on a 0 (not at all) to 3 (severely) scale. The reliability and validity of this 
measure have been well established (Beck, Epstein, Brown, & Steer, 1988; Freeston et al., 1994). 
The internal consistency was good in the current  sample  (α  =.88).  
Beck Depression Inventory-II (BDI-II; Beck et al., 1996). The BDI is a widely used 
self-report instrument designed to measure depressive symptoms. It consists of 21 items that 
correspond to symptoms of depression and are rated on a 0 to 3 scale.  The validity of the BDI 
with clinical and non-clinical samples has been well established (Beck, Steer, & Garbin, 1988) 
and demonstrated good  internal  consistency  in  the  current  sample  (α  =.90).   
Dimensional Obsessive-Compulsive Scale (DOCS; Abramowitz et al., 2010). The 
DOCS is a 20-item self-report measure that assesses the severity of the four most consistently 
replicated OCD symptom dimensions with four subscales: contamination, responsibility for harm 
and mistakes, symmetry/ordering, and unacceptable thoughts. To accommodate the 
heterogeneity of OCD symptoms each subscale begins with a description of the symptom 
dimension along with examples of representative obsessions and rituals. The examples clarify 
the form and function of each  dimension’s  core obsessional fears, compulsive rituals, and 
avoidance behaviors. Within each symptom dimension, five items (rated 0 to 4) assess the 
following parameters of severity over the past month: time occupied by obsessions and rituals, 
avoidance behavior, associated distress, functional interference, and difficulty disregarding the 
obsessions and refraining from the compulsions. The DOCS subscales have excellent reliability 
and validity in clinical and nonclinical samples (Abramowitz et al., 2010) and demonstrated 
excellent internal consistency in the current sample (α’s  =  .93-94).  
Obsessive Compulsive Inventory-Revised (OCI-R; Foa et al., 2002). The OCI-R is an 
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18-item self-report questionnaire that assesses distress associated with various obsessive–
compulsive symptoms. The OCI- R provides a total score (ranging from 0 to 72) and scores on 
six subscales: washing, checking, ordering, obsessing, hoarding, and neutralizing. The validity 
and reliability of this measure have been well established (Abramowitz & Deacon, 2006); this 
measure  demonstrated  good  internal  consistency  in  the  current  sample  (α  =  .88). In the present 
study, the OCI-R was used to classify participants in either the analogue or control groups based 
on the cut-off score determined to best distinguish between clinical and nonclinical individuals in 
the development of this measure (Foa et al., 2002).  
Obsessional Beliefs Questionnaire (OBQ; OCCWG, 2005). The OBQ-44 is a 44-item 
(rated 1 to 7) self-report questionnaire that measures dysfunctional obsessive beliefs 
hypothesized to underlie OCD symptoms. The OBQ-44 contains three subscales: responsibility 
and threat overestimation (RT; 16 items), perfectionism and need for certainty (PC; 16 items), 
and importance and control of thoughts (ICT; 12 items). This instrument has good validity, 
internal consistency, and reliability (OCCWG, 2005) and displayed excellent internal 
consistency in the current sample (α’s = .90-.93) 
Sheehan Disability Scale (SDS; Sheehan, 1983).  The SDS is a measure of role-
impairment caused by a medical or psychological disorder. It consists of three questions rated on 
a 10-point Likert scale assessing degree of impairment in three domains: work/school, social life, 
and family life/home responsibilities. The SDS is widely used and has established excellent 
internal consistency in a variety of community samples (Hambrick, Turk, Heimberg, Schneier & 
Liebowitz, 2004; Leon, Olfson, Portera, Farber & Sheehan, 1997; Mendlowicz & Stein, 2000); 
internal consistency  in  the  current  sample  was  also  excellent  (α  =  .90). In the present study, the 
SDS was used as a measure of impairment specific to OC symptoms.   
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Procedure  
Non-clinical groups. All data collection procedures were approved by the institutional 
review board (IRB) at the University of North Carolina at Chapel Hill. Participants in the control 
and analogue groups were recruited from the Psychology 101 Participant Pool. Students enrolled 
in the study via SONA, the online system used by the UNC Psychology Department. Since many 
of these unscreened participants were likely to fall into the control group, students who reported 
experiencing OC symptoms on a separate, internet-based study consisting entirely of self-report 
measures were invited to participate in the current study. This targeted recruitment allowed for 
the recruitment of similar sample sizes for both the analogue and control groups.  
Upon arrival at the laboratory, the experimenter first reviewed the informed consent form 
with participants and confirmed that participants were able to speak and read in English and was 
over 18. After consenting to participate in the study, the two interview-based measures were 
completed (MINI, YBOCS) with the examiner. Interviewers were highly trained research 
assistants and graduate students. During the administration of the Y-BOCS, participants were 
provided with the standard definitions of obsessions and compulsions as well as information 
regarding the percentage of the population that may experience these types of thoughts and 
behaviors. Since the Y-BOCS was designed for use with clinical populations, this was intended 
to make this measure as accessible as possible.  
Participants were then asked to complete the self-report measures, including the OCI-R, 
on a computer. Scores on this measure determined whether the participant was in the analogue or 
control group. The interviewers were thus blind to which group (analogue or control) participants 
were in, since participants completed the OCI-R after the interviews. The experimenter remained 
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in the room while the participant completed the self-report measures to answer questions. Lastly, 
participants were debriefed and given research credit for participation.  
Clinical group. Participants in the clinical group participated in one of two IRB 
approved treatment studies for OCD conducted at the UNC Psychology Department Community 
Clinic. Participants were recruited for these studies through online advertisements including 
campus-wide emails, newspaper advertisements, and referrals from other treatment providers. 
Interested participants were first screened over the phone to ensure the presence of OC 
symptoms. A trained interviewer then assessed these participants before starting treatment using 
the above measures (YBOCS, MINI, all self-report measures). The data from this initial, pre-
treatment assessment were used in the present study.
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RESULTS 
Demographic Characteristics  
Demographic characteristics by group are reported in Table 1. One-way analyses of 
variance (ANOVAs) and chi-square tests of independence were conducted to examine group 
differences on these variables. These analyses revealed no significant differences between groups 
on  ethnicity,  χ2(8) = 2.82, p = .95. There were, however, differences between the clinical group 
and  the  other  two  groups  in  terms  of  gender,  χ2(2) = 13.14, p = .01, with the clinical group 
including a higher proportion of female participants than both of the other groups. As expected, 
there were also differences between the clinical group and the other two groups in terms of age, 
F (2, 103) = 32.69, p < .01, with the clinical group being significantly older than the control and 
analogue groups. Given the between group differences on age and gender, we examined all 
subsequent analyses controlling for these factors as well as without these covariates; there were 
no differences in the pattern of results when controlling for age and gender.  
Obsessive Compulsive Symptoms 
Severity and frequency. To examine the hypothesis that the analogue group would score 
below the clinical group, but above the control group, on measures of OCD symptom severity, 
we conducted two one-way ANOVAs, comparing the three groups on their reported symptom 
severity as measured by the Y-BOCS. Group means are reported in Table 2. There were, in fact, 
significant differences between groups on both the Y-BOCS obsessions subscale, F (2, 103) = 
110.62, p < .01, η2 = .68, and the Y-BOCS compulsions subscale, F (2, 103) = 127.96, p < .01, 
η2 =  .71.  Tukey’s  HSD  post-hoc tests revealed that for both of these dependent variables there
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were significant differences between each of the three groups (p’s  <.01),  such  that  the  clinical  
group reported significantly more severe and frequent OC symptoms than the analogue and 
control groups, and the analogue group reported significantly more severe and frequent OC 
symptoms than the control group. Identical patterns were present for obsessions and 
compulsions.  
Content domains. To examine the hypothesis regarding OC symptom content, we 
conducted four one-way ANOVAs, comparing the three groups on symptom severity within four 
symptom content domains as measured by the DOCS. Group means are reported in Table 2. 
There were significant differences between groups on the contamination subscale, F (2, 103) = 
33.94, p < .01, η2 = .40, the responsibility for harm subscale, F (2, 103) = 30.02, p < .01, η2 = 
.37, the unacceptable thoughts subscale, F (2, 103) = 20.03, p < .01, η2 = .28, and the symmetry 
subscale, F (2, 103) = 10.97, p < .01, η2 =  .18.  Tukey’s  HSD  post-hoc tests revealed that there 
were significant differences between each of the three groups on contamination (p’s  <  .05),  
responsibility for harm (p’s  <  .01),  and  unacceptable  thoughts  (p’s  <  .05), with the clinical group 
reporting significantly more severe OC symptoms than the control and analogue groups, and the 
analogue group reporting significantly more severe symptoms than the control group. For the 
symmetry subscale, there were significant differences between the control group and both the 
analogue and clinical groups (p’s  <  .01);;  however  there  was  not  a  significant  difference  between  
the analogue group and the clinical group (p = .57).  
Obsessions. To examine whether the presence of specific obsessions differed between 
groups, we conducted a series of chi-squared tests of independence with obsessional content 
domains on the Y-BOCS checklist as dependent variables. Given the number of comparisons, a 
Bonferroni correction was used. Results of these analyses are reported in Table 3. As can be 
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seen, both the analogue and clinical groups more frequently endorsed obsessions related to 
responsibility for harm, contamination, sexual thoughts, symmetry, as well as miscellaneous 
obsessions when compared to the control group. On each of these domains there were no 
significant differences between the clinical and analogue groups. There were no significant 
differences between any of the three groups on scrupulosity obsessions. Finally, the clinical 
group more frequently endorsed somatic obsessions when compared with the control group, but 
there were no significant differences between the analogue group and the other two groups. 
Furthermore, all participants in both the analogue and clinical groups reported the presence of at 
least one obsession; this was significantly higher than in the control group.  
 Compulsions. To examine whether the presence of specific compulsions differed 
between groups, we conducted a series of chi-squared tests of independence with compulsion 
content domains on the Y-BOCS checklist as dependent variables. Given the number of 
comparisons, a Bonferroni correction was used. Results of these analyses are reported in Table 4. 
As can be seen, both the analogue and clinical groups more frequently endorsed washing, 
repeating, counting, and mental compulsions when compared to the control group. On each of 
these domains there were no significant differences between the clinical and analogue groups. 
Furthermore, the clinical group reported significantly more checking and miscellaneous 
compulsions than did both the analogue and control groups, and the analogue group more 
frequently endorsed checking and miscellaneous compulsions than the control group. Finally, the 
clinical group more frequently endorsed ordering compulsions when compared with the control 
group, but there were no significant differences between the analogue group and the other two 
groups on this domain. Furthermore, all participants in both the analogue and clinical groups 
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reported the presence of at least one compulsion; this was significantly higher than in the control 
group. 
Obsessional Beliefs 
To test the hypothesis regarding obsessional beliefs, we conducted three one-way 
ANOVAs, comparing groups on the three subscales of the OBQ.  Group means are reported in 
Table 2. There were significant differences between groups on the RT subscale, F (2, 103) = 
26.70, p < .01, η2 = .34, the PC subscale, F (2, 103) = 10.79, p < .01, η2 = .18, and the ICT 
subscale, F (2, 103) = 20.76, p < .01, η2 =  .29.  Tukey’s  HSD  post-hoc tests revealed that there 
were significant differences between each of the three groups on the RT subscale (p’s  <  .05),  
with the clinical group endorsing stronger obsessional beliefs than the analogue and control 
groups, and the analogue group endorsing stronger obsessional beliefs than the control group. On 
both the PC and ICT subscales, the clinical and analogue groups reported significantly higher 
levels of obsessional beliefs than the control group (p’s  <  .01).  There  were  no  differences  
between the clinical and analogue groups on these subscales.  
To determine whether specific OC symptoms were related to specific obsessional beliefs, 
we computed Pearson correlation coefficients between the four symptom domains as measured 
by the DOCS and the three types of obsessional beliefs as measured by the OBQ. These 
correlations in the overall sample are reported in Table 5. As can be seen, the DOCS 
contamination subscale was significantly correlated with the RT subscale of the OBQ; the DOCS 
harm subscale was significantly correlated with all three obsessional belief domains; the DOCS 
thoughts subscale was significantly correlated with the OBQ RT and ICT subscales; and the 
DOCS symmetry subscale was significantly correlated with the OBQ PC subscale.  
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Identical analyses were conducted within each group and are reported in Table 6. In the 
control group, the DOCS harm subscale was significantly correlated with both the RT and PC 
subscales of the OBQ. This pattern was identical in the clinical group, but not in the analogue 
group. Additionally, there was a significant relationship between the DOCS thoughts subscale 
and the ICT subscale of the OBQ only within the clinical group. There were no other significant 
relationships between OC symptoms and obsessional beliefs within any of the groups. Further, 
tests of equivalence revealed that the strength of these correlation coefficients significantly 
differed between (a) the clinical and control groups on the following domains: DOCS 
contamination with OBQ ICT (p < .01), and DOCS thoughts with OBQ ICT (p < .01); (b) the 
clinical and analogue groups on the following domains: DOCS harm with OBQ PC (p = .03), 
and DOCS thoughts with OBQ ICT (p = .01); and (c) the control and analogue groups on the 
following domain: DOCS harm with OBQ PC (p = .04).  
Symptom Impairment  
To test the hypothesis that the analogue group would score below the clinical group, but 
above the control group on the measure of symptom impairment, we conducted a one-way 
ANOVA with SDS scores as the dependent variable. Group means are reported in Table 2. We 
found a significant difference between groups, F (2, 89) = 42.64, p < .01, η2 =  .49.  Tukey’s  HSD  
post-hoc tests revealed that there were significant differences between each of the three groups 
(p’s  <  .01),  with  the  clinical  group  reporting  greater  symptom  impairment than the analogue and 
control groups and the analogue group reporting greater impairment than the control group.  
Psychiatric Comorbidity  
To test the hypothesis that the analogue group scored below the clinical group, but above 
the control group on measures of psychiatric comorbidity we conducted two one-way ANOVAs, 
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comparing the three groups on mood and anxiety symptoms as measured by the BDI and BAI.  
Group means are reported in Table 2. There were significant differences between groups on both 
the BDI, F (2, 103) = 14.71, p < .01, η2 = .22, and the BAI, F (2, 89) = 12.60, p < .01, η2 = .22. 
Tukey’s  HSD  post-hoc tests revealed that on the BDI, the clinical group reported higher levels of 
depression than both the analogue and control groups (p’s  < .05); there was no significant 
difference between the analogue and control groups. On the BAI, however, the clinical and 
analogue groups reported significantly higher levels of anxiety than did the control group (p’s  <  
.01). There was not a significant difference between the clinical and analogue groups.  
Additionally, to compare the three groups on rates of diagnostic comorbidity as measured 
by the MINI, we conducted a series of chi-squared tests. Given the number of comparisons, a 
Bonferroni correction was used. Results of these analyses are reported in Table 7. As can be 
seen, significantly higher percentages of the analogue and clinical groups were diagnosed with 
generalized anxiety disorder (GAD) relative to the control group, with no differences between 
these groups. Furthermore, significantly higher percentages of both the analogue and clinical 
groups were diagnosed with any comorbid condition relative to the control group. There were no 
other between group differences.
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DISCUSSION 
The aim of the present study was to evaluate the utility of research employing OC 
analogue samples by comparing an analogue group to clinical and control groups on the 
following domains: OC symptoms, obsessional beliefs, symptom impairment, and psychiatric 
comorbidity. We found that the analogue group did not differ from the clinical group in terms of 
the severity of symmetry OC symptoms, the presence of both obsessions and compulsions across 
content areas, patterns of comorbidity, and levels of obsessional beliefs. Additionally, consistent 
with dimensional conceptualizations of OCD, the analogue group appeared to be quantitatively, 
but not qualitatively, different from the clinical group with regard to OC symptom severity, 
symptom frequency, and related impairment. The relationship between obsessional beliefs and 
OC symptoms, however, appears to be a notable exception to the above findings and may 
represent an important area of difference between analogue and clinical samples.  
On the whole, our hypotheses regarding OCD symptom severity and frequency were 
supported.  Specifically, the analogue group reported significantly fewer and less severe OC 
symptoms than the clinical group but significantly greater and more severe OC symptoms than 
the control group. This was expected, in part, based on our method of categorizing participants in 
the analogue or control group based on their self-reported OC symptom severity. However, the 
measure used to group participants greatly emphasizes compulsions and does not thoroughly 
address different obsessional content domains. Furthermore, the current study found that a 
similar pattern emerged for both obsessions and compulsions as measured by a clinical 
interview, as well as across OC symptom content domains with only one exception: the analogue
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group reported similar levels of symmetry and ordering symptoms relative to the clinical group.  
These findings provide support for the view that analogue samples represent sub-clinical 
presentations of OCD that are similar in content and form, and different only in severity, from 
clinical samples. Furthermore, when viewed in concert with dimensional conceptualizations of 
OCD (Abramowitz et al., 2014), these results support the generalizability of data from analogue 
samples to understanding clinical presentations of OCD.  
These findings also indicate that research focused on symmetry and ordering symptoms 
may be particularly well-suited to the use of analogue samples. While we expected that the 
clinical and analogue groups would report different levels of symmetry symptom severity, these 
findings are consistent with previous research suggesting that symmetry symptoms may be 
underrepresented in treatment-seeking samples (Ball, Baer, & Otto, 1996). That is, rather than 
the analogue group reporting particularly high levels of symmetry symptom severity, the clinical 
group reported relatively moderate levels of symmetry symptom severity that are similar to rates 
reported in prior research (Pinto, Mancebo, Eisen, Pagano, & Rasmussen, 2006). One possible 
explanation for this is that symmetry symptoms have been found to overlap with symptoms of 
obsessive compulsive personality disorder in individuals with OCD (Coles, Pinto, Mancebo, 
Rasmussen, & Eisen, 2008). These symptoms may thus be experienced as less personally 
distressing (i.e. more ego-syntonic) than other OCD symptoms, and this may prevent individuals 
who primarily experience symmetry symptoms from seeking treatment. While results from the 
current study indicate substantial overlap between the analogue and clinical groups in terms of 
symmetry symptom severity, future research comparing a purely clinical, rather than a treatment-
seeking sample, to an analogue sample would clarify these findings.  
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In addition to OC symptom severity and frequency, the current study also examined the 
frequency with which participants endorsed specific categories of obsessions and compulsions. 
Overall, we found few differences between the analogue and clinical groups on the presence of 
specific obsessions and compulsions, with the analogue group reporting almost identical patterns 
of obsessions and compulsions to the clinical group.  That is, the analogue group was not 
significantly different from the clinical group on any obsessional domains, and only significantly 
differed from the clinical group with regard to the frequency of endorsing checking and 
miscellaneous compulsions. Despite previous research suggesting that washing and cleaning 
compulsions may be relatively uncommon outside of clinical populations (Degonda et al., 1993; 
Valleni-Basile et al., 1994), the current study did not find a significant difference between the 
analogue and clinical groups on this domain. These results indicate that analogue samples may 
be appropriate in research examining all types of obsessions and compulsions, including cleaning 
and washing symptoms.   
Furthermore, significantly higher proportions of the analogue and clinical groups 
endorsed both obsessions and compulsions relative to the control group. Contrary to prior 
research suggesting that individuals with sub-clinical OCD were more likely to experience only 
obsessions or compulsions (Karno, et al., 1988; Weissman et al., 1994), the current study found 
that the entirety of the analogue group reported the presence of both obsessions and compulsions. 
This pattern was identical to that in the clinical group, but significantly differed from that in the 
control group. Consistent with the CB model, it seems that a functional relationship between 
obsessions and compulsions exists in sub-clinical presentations of OCD. This finding provides 
additional support for the generalizability and utility of analogue samples, since the function, as 
well as the form, of OC symptoms does not differ between sub-clinical and clinical OCD.  
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We found mixed support for our hypotheses regarding obsessional beliefs. As we 
expected, there were significant differences between each of the three groups in terms of 
responsibility and threat overestimation, with the clinical group reporting significantly greater 
obsessional beliefs than the other two groups, and the analogue group reporting greater 
obsessional beliefs than the control group. For obsessional beliefs about perfection and certainty, 
as well as about the importance and need to control thoughts, we found no differences between 
the analogue and clinical groups, with both of these groups reporting significantly greater 
obsessional beliefs than controls. Taken together, these results suggest that individuals with sub-
clinical OCD may not experience different levels of dysfunctional cognitions relative to those 
with clinical OCD, and thus provide additional support for the generalizability of data drawn 
from analogue samples.  
 Contrary to our hypotheses, however, we did not find similar patterns across groups with 
regard to the relationships between obsessional beliefs and OC symptoms. In the overall sample, 
we found positive associations between specific OC symptoms and specific obsessional beliefs 
consistent with previous research (OCCWG, 2005). Yet when these relationships were examined 
within the three groups, significant associations between symptoms and cognitions were only 
present in the control and clinical groups. That is, there were no significant relationships between 
any OC symptoms and obsessional beliefs in the analogue group. While the analogue group 
reported similar levels of obsessional beliefs relative to the clinical group, these cognitions did 
not appear to be related to OC symptoms as expected based on previous research. Thus, the 
extent to which obsessional beliefs are important psychological mechanisms involved in 
analogue OC symptoms is not clear and differs from what has been previously established (and 
what we found in the present study) in both nonclinical and clinical samples. Accordingly, 
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results from research using analogue samples to study the relationship between OC symptoms 
and obsessional beliefs should be interpreted with caution.  
There are a number of possible explanations for the above findings. First, range 
restriction and small sample size may account, in part, for these results. Another explanation is 
simply that the associations between maladaptive cognitions and OC symptoms are weaker in 
analogue samples than they are in clinical groups; thus representing an area of important 
difference between these groups. It is possible that analogue groups include individuals who 
endorse high levels of obsessional beliefs, but who do not yet experience severe OC symptoms. 
In this case, obsessional beliefs might not be related to current levels of OC symptoms, but are 
possibly predictive of the future development of such symptoms. Furthermore, analogue groups 
may also include individuals who currently experience moderate levels of OC symptoms, but 
whose symptoms are transient and not connected to obsessional beliefs. While previous research 
has examined the conceptualization of sub-clinical OCD as a premorbid form of OCD, these 
studies are limited and results have been mixed (Coles, Hart & Schofield, 2012; Fullana et al., 
2009; Valleni-Basile et al., 1996). Prospective research addressing the role that obsessional 
beliefs may play in sub-clinical OCD is warranted.  
 Our third hypothesis that the analogue group would score below the clinical group, but 
above the control group on measures of impairment related to OC symptoms was supported. The 
analogue group reported significantly more impairment at work, at home, and in interpersonal 
contexts than did the control group, but significantly less impairment than did the clinical group. 
On average, the analogue group reported mild to moderate impairment. These findings replicate 
previous research that has found similar patterns (Adam et al., 2012; Fineberg et al., 2013; Grabe 
et al., 2000) and thus support a dimensional model of impairment related to OC symptoms. This 
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provides additional evidence that research using analogue samples is likely relevant to 
understanding clinical OCD.  
 We found mixed support for our hypothesis that the analogue group would score below 
the clinical group, but above the control group on measures of psychiatric comorbidity. 
Specifically, both the analogue and clinical groups reported significantly greater general anxiety 
than did the control group, while the analogue and control groups reported significantly fewer 
symptoms of depression than did the clinical group. In this way, the analogue group appeared to 
overlap with the clinical group in terms of general anxiety, yet overlap with the control group in 
terms of depression. Since the clinical group reported higher levels of distress and impairment 
related to OCD, this may be reflected in their report of depression symptoms in the mild to 
moderate range. It was surprising that there was not a difference in depression symptoms 
between the analogue and control groups, given previous research reporting that analogue 
samples displayed higher levels of depression than did controls (e.g. Sher et al., 1991). Notably, 
while there was not a significant difference in the current study, we observed scores on the BDI 
in the analogue group that were consistent with mild levels of depression, while the control 
group reported lower levels consistent with little to no depressive symptoms.  
Additionally, we found few differences between the three groups in terms of rates of 
comorbidity. This was somewhat surprising given the high rates of comorbidity often seen in 
OCD (Karno et al., 1988; Tukel et al., 2002), however it may reflect the low base rates of these 
individual disorders. That is, while the majority of the clinical group met criteria for a comorbid 
diagnosis (60%), the rates for each particular condition were much lower. As an exception, we 
found that GAD was diagnosed in a significantly higher number of analogue and clinical 
participants relative to the control group. Furthermore, a significantly higher proportion of both 
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the clinical and analogue groups were diagnosed with any comorbid disorder compared to the 
control group, indicating that participants in the analogue and clinical groups experienced 
significant higher rates of comorbidity than the control group. These results partially replicate 
previous findings that individuals with sub-clinical OCD endorse lower rates of psychiatric 
comorbidity than clinical groups, but higher rates than controls (Adam et al., 2012; de Bruijn et 
al., 2010; Grabe et al., 2001). Given the general similarity in patterns of comorbidity between the 
analogue and clinical groups, and differences between the analogue and control groups, these 
findings provide additional support for the generalizability of analogue samples to clinical 
samples. 
 Finally, we also observed differences between groups with regard to demographic 
characteristics. Specifically, we found that the clinical group was significantly older than the 
other two groups. This was expected, since the analogue and control groups were composed of 
undergraduate students in order to maximize ecological validity. Notably, the pattern of results 
observed in this study did not change when controlling for age; thus age does not account for the 
observed between group differences. This is consistent with previous research that has not found 
age to be significantly related to OCD symptom presentation or related features (Valleni-Basile 
et al., 1995).  
The current study also observed between group differences in gender, with the clinical 
group including a significantly higher proportion of women than the other two groups. This was 
somewhat surprising, as previous research has generally found few gender differences in rates of 
OCD in adulthood (Karno et al., 1988; Torres et al., 2006; Weissman et al., 1994). A recent 
population-based cohort study, however, found higher rates of females than males in a clinical 
sample, but slightly higher rates of males than females in a sub-clinical sample (Fineberg et al., 
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2013). These findings are similar to those observed in the current study, but are an exception to 
the large body of research on this topic. It is possible that the high percentage of women in the 
clinical group is not representative of typical clinical samples, and instead may be related to the 
fact that this was a treatment-seeking group, as previous research has found that women seek 
treatment more often than men for a variety of conditions (Rhodes et al., 2002; Wang et al., 
2005). Even if systematic gender differences do exist, controlling for gender did not change the 
pattern of results and thus does not explain the between-group differences observed in the current 
study. This is consistent with previous research that has not found gender to be a predictor of 
OCD symptom severity or related features (Bogetto et al., 1999; Labad et al., 2008; Tükel et al., 
2004). Future research comparing analogue samples to clinical, but not necessarily treatment 
seeking, samples may clarify gender differences between these groups. 
Limitations and Future Directions 
 Several limitations of the current study should be noted.  First, this study is cross-
sectional in nature and thus cannot adequately address causal issues regarding the development 
and maintenance of OC symptoms. Second, the clinical group in this study was composed of 
individuals who were seeking treatment for OCD, and may differ from non-treatment seeking 
individuals with OCD in a number of ways (e.g. gender ratio, symptom impairment). Third, as 
previously mentioned, the analogue and control groups were made up of undergraduate students. 
While this was done intentionally to increase ecological validity, there may be differences 
between students and non-students with sub-clinical OCD (e.g. age). Finally, the smaller sample 
size of the analogue group, and range restriction relative to how groups were defined, may have 
reduced our ability to detect between group differences. This final limitation is partially 
mitigated, however, since assumptions regarding homogeneity of variance were not violated.  
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 In order to further our understanding of the utility of OC analogue research, future 
research should examine the longitudinal course of OCD, with a particular focus on mechanisms 
related to the development of OC symptoms. This research would help clarify the nature of OC 
analogue samples; that is, whether sub-clinical OCD is best conceptualized as a pre-morbid form 
of OCD. Prospective research would also enhance our understanding of the relationship between 
psychological mechanisms and OC symptoms within individuals with sub-clinical OCD. Finally, 
research comparing analogue samples recruited from the general population to clinical, but not 
necessarily treatment seeking, samples would reduce sampling bias and thus further clarify the 
differences between analogue and clinical samples.  
Conclusion 
In sum, results from the current study provide general support for the use and utility of 
OC analogue samples. Consistent with dimensional conceptualizations of OCD, research 
employing these samples is likely to generate findings that are relevant to clinical OCD.  
In particular, the analogue group exhibited substantial overlap with the clinical group (and was 
different from controls) in terms of the severity of symmetry OC symptoms, the presence of both 
obsessions and compulsions across content areas, patterns of comorbidity, and levels of 
obsessional beliefs. The use of analogue samples may be particularly appropriate in research 
focused on these areas. Additionally, the analogue group appeared to be quantitatively, but not 
qualitatively, different from the clinical group in terms of OC symptom severity and frequency 
across content domains, and symptom impairment. These findings support the view that OC 
symptom severity and impairment occur on a continuum on which analogue samples exist below 
the clinical group, but above the control group. Finally, an important area of difference between 
sub-clinical and clinical OCD may be in the relationship between obsessional beliefs and OC 
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symptoms. Based on the current study, research examining this relationship in analogue samples 
is not expected to generalize to clinical samples, and thus should be conducted and viewed with 
caution.  
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Table 1  
Demographic Characteristics by Group 
Demographics  Control Analogue Clinical 
Mean age (SD) 20.85 (5.76) 19.92 (2.00) 32.60 (10.60) 
No. Female (%) 29 (39.1) 15 (60.0) 33 (94.3) 
Racial/ethnic background    
No. White (%) 33 (71.7) 18 (72.0) 28 (80.0) 
No. Latino (%) 2 (4.3) 2 (8.0) 2 (5.7) 
No. African Amer. (%) 6 (13.0) 2 (8.0) 2 (5.7) 
No. Asian (%) 2 (4.3) 2 (8.0) 1 (2.9) 
      No. Other (%) 3 (6.5) 1 (4.0) 2 (5.7) 
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Table 2 
Means (and Standard Deviations) for All Measures by Group 
 Control  Analogue  Clinical  
YBOCS Obsessions 3.04 (3.37)a 5.20 (2.89)b 12.89 (2.58)c 
YBOCS Compulsions 2.37 (2.52)a 6.00 (3.20)b 13.17 (3.47)c 
DOCS Contamination 1.83 (2.09)a 4.40 (2.92)b 9.26 (6.13)c 
DOCS Harm 2.22 (2.52)a 6.08 (3.90)b 9.34 (5.69)c 
DOCS Thoughts 2.20 (2.40)a 5.20 (3.95)b 8.06 (5.78)c 
DOCS Symmetry 1.67 (2.24)a 5.36 (3.16)b 4.43 (4.85)b 
OBQ RT 51.20 (13.46)a 67.00 (15.43)b 79.46 (22.51)c 
OBQ PC 57.15 (14.97)a 73.72 (14.88)b 73.91 (23.72)b 
OBQ ICT 27.30 (10.05)s 38.24 (11.51)b 46.21 (17.16)b 
BAI 6.57 (4.63)a 12.08 (8.10)b 15.48 (9.95)b 
BDI 6.76 (6.02)a 10.48 (7.82)a 15.74 (8.60)b 
SDS   3.91 (4.21)a 8.76 (5.80)b 17.24 (7.34)c 
Means with different subscripts are significantly different from each other (p < .05).  
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Table 3 
Frequencies (and %) of Obsessional Content by Group 
 Group 
Chi-Square p 
 
 
Obsessions 
Control 
(n =46) 
Analogue 
(n = 24) 
Clinical 
(n = 31) 
      
Harm 12 (26%) a 13 (54%) b 22 (71%) b 15.73 <.01 
Contamination 21 (46%) a 20 (83%) b 26 (84%) b 16.19 <.01 
Sexual 1 (2%) a 5 (21%) b 10 (32%) b 13.16 <.01 
Scrupulosity 6 (13%)a 7 (30%) a 10 (32%) a 4.62 .10 
Symmetry 8 (17%) a 11 (46%) b 15 (48%) b 10.06 <.01 
Somatic 12 (26%) a 10 (42%)a, b 18 (58%) b 7.97 .02 
Misc 17 (37%) a 19 (79%) b 21 (68%) b 13.76 <.01 
Any obsession 37 (80%)a 24 (100%)b 31 (100%)b 11.81 <.01 
Frequencies with different subscripts are significantly different from each other using a 
Bonferroni correction.  
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Table 4 
Frequencies (and %) of Compulsion Content by Group 
 Group 
Chi-Square p 
 
 
Compulsions 
Control 
(n = 46) 
Analogue 
(n =24) 
Clinical 
(n = 31) 
      
Washing 10 (22%) a 13 (54%) b 23 (74%) b 21.49 <.01 
Checking 15 (33%) a 17 (71%) b 30 (97%) c 33.35 <.01 
Repeating 2 (4%) a 10 (42%) b 12 (39%) b 17.64 <.01 
Counting 1 (2%) a 8 (33%) b 8 (26%) b 13.51 <.01 
Ordering 3 (6%) a 5 (21%) a, b 14 (45%) b 16.25 <.01 
Mental 14 (30%) a 16 (67%) b 25 (81%) b 20.72 <.01 
Misc 15 (33%) a 15 (63%) b 30 (97%) c 31.74 <.01 
Any compulsion 30 (65%)a 24 (100%)b 31 (100%)b 22.73 <.01 
Frequencies with different subscripts are significantly different from each other using a 
Bonferroni correction.  
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Table 5 
Correlations between OC Symptoms and Obsessional Beliefs 
 OBQ RT OBQ PC OBQ ICT 
    
DOCS Contamination .41* .26 .21 
DOCS Harm .68* .50* .33* 
DOCS Thoughts .30* .25 .55* 
DOCS Symmetry .22 .37* .19 
*significant after Bonferroni adjustment, p < .004
 
 
 
Table 6 
Correlations between OC Symptoms and Obsessional Beliefs by Group  
Group 
Control Analogue Clinical 
OBQ RT OBQ PC OBQ ICT OBQ RT 
OBQ 
PC OBQ ICT OBQ RT OBQ PC OBQ ICT 
DOCS Contam .28 -.01 .24 .11 .19 -.09 .02 .05 -.36 
DOCS Harm .50* .43* .12 .19 -.08 -.38 .61* .48* .04 
DOCS Thoughts -.01 .14 -.06 -.11 -.01 .05 .01 .05 .64* 
DOCS Symmetry .02 .16 .08 -.22 .12 -.03 .11 .32 -.02 
*significant after Bonferroni adjustment, p < .001 
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Table 7 
Frequencies (and %) of Comorbid Diagnoses by Group 
 Group 
Chi-
Square p 
 
Diagnosis 
Control  
(n= 46) 
Analogue  
(n = 24) 
Clinical 
(n = 31) 
      
Depression 2 (4%) a 3 (12%) a 2 (6.5%) a 1.50 .47 
Dysthymia 0 (0%)a 1 (4%)a 3 (9.7%)a 4.60 .10 
Manic Episode 0 (0%) a 0 (0%) a 1 (3%) a 2.28 .32 
Hypomanic Episode 3 (7%)a 4 (17%) a 0 (0%) a 5.85 .05 
Panic Disorder 1 (2%) a 0 (0%) a 4 (13%) a 6.17 .05 
Social Phobia 0 (0%) a 2 (8%) a 3 (10%) a 4.45 .11 
PTSD 0 (0%) a 0 (0%) a 0 (0%) a -- -- 
Alcohol Dependence 3 (7%) a 1 (4%) a 1 (3%) a 2.07 .35 
Alcohol Abuse 1 (2%) a 4 (17%) a 1 (3%) a 6.52 .04 
Substance Dependence 3 (7%) a 1 (4%) a 0 (0%) a 2.07 .35 
Substance Abuse 3 (7%) a 1 (4%) a 0 (0%) a 2.07 .35 
Psychotic Disorder 0 (0%) a 0 (0%) a 0 (0%) a -- -- 
Anorexia Nervosa 0 (0%) a 0 (0%) a 0 (0%) a -- -- 
Bulimia Nervosa 0 (0%) a 2 (8%) a 1 (3%) a 3.81 .15 
GAD 4 (9%) a 9 (36%) b 8 (26%) b 8.63 .01 
Antisocial PD 0 (0%) a 0 (0%) a 0 (0%) a -- -- 
Any diagnosis 14 (30%)a 15 (60%)b 18 (60%)b 8.80 .01 
Frequencies with different subscripts are significantly different from each other using a 
Bonferroni correction. 
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